Breast Cancer Liquid Biopsy Market Size, Share, Trends, Growth 2028
Breast Cancer Liquid Biopsy Market By Product (Assay Kits, Instruments, & Services), By Application (Cancer Diseases, Non-Cancer Disease, & Others), By End User (Hospitals, Laboratories, Research Centers, & Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028
| Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 87.64 Million | USD 357.05 Billion | 19.9% | 2021 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Breast Cancer Liquid Biopsy Market, (2022 - 2028) (USD Billion)
- 2.2 Global Breast Cancer Liquid Biopsy Market : snapshot
- Chapter 3. Global Breast Cancer Liquid Biopsy Market - Industry Analysis
- 3.1 Breast Cancer Liquid Biopsy Market: Market Dynamics
- 3.2 Market Drivers
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End-User
- Chapter 4. Global Breast Cancer Liquid Biopsy Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Breast Cancer Liquid Biopsy Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Breast Cancer Liquid Biopsy Market - Product Analysis
- 5.1 Global Breast Cancer Liquid Biopsy Market overview: By Product
- 5.1.1 Global Breast Cancer Liquid Biopsy Market share, By Product, 2021 and 2028
- 5.2 Assay Kits
- 5.2.1 Global Breast Cancer Liquid Biopsy Market by Assay Kits, 2022 - 2028 (USD Billion)
- 5.3 Instruments
- 5.3.1 Global Breast Cancer Liquid Biopsy Market by Instruments, 2022 - 2028 (USD Billion)
- 5.4 Services
- 5.4.1 Global Breast Cancer Liquid Biopsy Market by Services, 2022 - 2028 (USD Billion)
- 5.1 Global Breast Cancer Liquid Biopsy Market overview: By Product
- Chapter 6. Global Breast Cancer Liquid Biopsy Market - Application Analysis
- 6.1 Global Breast Cancer Liquid Biopsy Market overview: By Application
- 6.1.1 Global Breast Cancer Liquid Biopsy Market share, By Application, 2021 and 2028
- 6.2 Cancer Diseases
- 6.2.1 Global Breast Cancer Liquid Biopsy Market by Cancer Diseases, 2022 - 2028 (USD Billion)
- 6.3 Non-Cancer Diseases
- 6.3.1 Global Breast Cancer Liquid Biopsy Market by Non-Cancer Diseases, 2022 - 2028 (USD Billion)
- 6.4 Others
- 6.4.1 Global Breast Cancer Liquid Biopsy Market by Others, 2022 - 2028 (USD Billion)
- 6.1 Global Breast Cancer Liquid Biopsy Market overview: By Application
- Chapter 7. Global Breast Cancer Liquid Biopsy Market - End-User Analysis
- 7.1 Global Breast Cancer Liquid Biopsy Market overview: By End-User
- 7.1.1 Global Breast Cancer Liquid Biopsy Market share, By End-User, 2021 and 2028
- 7.2 Hospitals
- 7.2.1 Global Breast Cancer Liquid Biopsy Market by Hospitals, 2022 - 2028 (USD Billion)
- 7.3 Laboratories
- 7.3.1 Global Breast Cancer Liquid Biopsy Market by Laboratories, 2022 - 2028 (USD Billion)
- 7.4 Research Centers
- 7.4.1 Global Breast Cancer Liquid Biopsy Market by Research Centers, 2022 - 2028 (USD Billion)
- 7.5 Others
- 7.5.1 Global Breast Cancer Liquid Biopsy Market by Others, 2022 - 2028 (USD Billion)
- 7.1 Global Breast Cancer Liquid Biopsy Market overview: By End-User
- Chapter 8. Breast Cancer Liquid Biopsy Market - Regional Analysis
- 8.1 Global Breast Cancer Liquid Biopsy Market Regional Overview
- 8.2 Global Breast Cancer Liquid Biopsy Market Share, by Region, 2021 & 2028 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Myriad Genetics Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Sysmex Corporation
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Fluxion Biosciences Inc.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Biocept Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Qiagen N.V.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Thermo Fisher Scientific Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Biodesix Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Isogen Life Science B.V.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.1 Myriad Genetics Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Breast Cancer Liquid Biopsy Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Breast Cancer Liquid Biopsy Market attractiveness, By Product
- 6. Global Breast Cancer Liquid Biopsy Market attractiveness, By Application
- 7. Global Breast Cancer Liquid Biopsy Market attractiveness, By End-User
- 8. Global Breast Cancer Liquid Biopsy Market share by Product, 2022 and 2028 (USD Billion)
- 9. Global Breast Cancer Liquid Biopsy Market by Assay Kits, 2022 - 2028 (USD Billion)
- 10. Global Breast Cancer Liquid Biopsy Market by Instruments, 2022 - 2028 (USD Billion)
- 11. Global Breast Cancer Liquid Biopsy Market by Services, 2022 - 2028 (USD Billion)
- 12. Global Breast Cancer Liquid Biopsy Market share by Application, 2022 and 2028 (USD Billion)
- 13. Global Breast Cancer Liquid Biopsy Market by Cancer Diseases, 2022 - 2028 (USD Billion)
- 14. Global Breast Cancer Liquid Biopsy Market by Non-Cancer Diseases, 2022 - 2028 (USD Billion)
- 15. Global Breast Cancer Liquid Biopsy Market by Others, 2022 - 2028 (USD Billion)
- 16. Global Breast Cancer Liquid Biopsy Market share by End-User, 2022 and 2028 (USD Billion)
- 17. Global Breast Cancer Liquid Biopsy Market by Hospitals, 2022 - 2028 (USD Billion)
- 18. Global Breast Cancer Liquid Biopsy Market by Laboratories, 2022 - 2028 (USD Billion)
- 19. Global Breast Cancer Liquid Biopsy Market by Research Centers, 2022 - 2028 (USD Billion)
- 20. Global Breast Cancer Liquid Biopsy Market by Others, 2022 - 2028 (USD Billion)
- 21. Global Breast Cancer Liquid Biopsy Market share, by Region, 2022 and 2028
Table Of Tables
- 1. Global Breast Cancer Liquid Biopsy Market: Snapshot
- 2. Drivers of the Breast Cancer Liquid Biopsy Market: impact analysis
Methodology
FrequentlyAsked Questions
Increased preference for non-invasive biopsy procedures in the American and European markets is contributing to the growth of breast cancer liquid biopsy. A rise in the global occurrence of breast cancer is also helping in the growth of the same.
According to Zion Market Research, the breast cancer liquid biopsy market is predicted to grow to USD 357.05 billion by 2028, up from USD 87.64 million in 2021. The global breast cancer liquid biopsy market is expected to grow at a CAGR of 19.9 percent over the forecast period.
Due to increased efforts by governments and awareness groups, Asia Pacific is growing significantly. The North American region is also expected to hold a large market share for the forecast period given the trend toward non-invasive biopsy procedures.
Some of the prominent institutes, medical centers, companies, and diagnostic centers that are key players in the breast cancer liquid biopsy market and include Myriad Genetics Inc., Sysmex Corporation, Fluxion Biosciences Inc., Biocept Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Biodesix Inc., and Isogen Life Science B.V.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed